SZSE:300765 (China)
Â
Class A
Â¥
27.55
(+0.51%)
Dec 27
Business Description
CSPC Innovation Pharmaceutical Co Ltd
ISIN : CNE100003K04
Share Class Description:
SZSE:300765: Class ACompare
Compare
Traded in other countries / regions
300765.China IPO Date
2019-03-22Description
CSPC Innovation Pharmaceutical Co Ltd is engaged in Research and development, production and sales of functional foods.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1236.66 | |||||
| Equity-to-Asset | 0.67 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 24.65 | |||||
| Beneish M-Score | -1.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 17.3 | |||||
| 3-Year EBITDA Growth Rate | 26.3 | |||||
| 3-Year EPS without NRI Growth Rate | 34 | |||||
| 3-Year FCF Growth Rate | 45.1 | |||||
| 3-Year Book Growth Rate | 16.8 | |||||
| Future 3-5Y Total Revenue Growth Rate | 39.98 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.04 | |||||
| 9-Day RSI | 48.67 | |||||
| 14-Day RSI | 48.41 | |||||
| 6-1 Month Momentum % | 13.13 | |||||
| 12-1 Month Momentum % | -3.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.69 | |||||
| Quick Ratio | 2.32 | |||||
| Cash Ratio | 1.48 | |||||
| Days Inventory | 82.96 | |||||
| Days Sales Outstanding | 74.41 | |||||
| Days Payable | 83.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.17 | |||||
| Dividend Payout Ratio | 0.86 | |||||
| 3-Year Dividend Growth Rate | 73.3 | |||||
| Forward Dividend Yield % | 1.17 | |||||
| 5-Year Yield-on-Cost % | 1.17 | |||||
| 3-Year Average Share Buyback Ratio | -6 | |||||
| Shareholder Yield % | 1.27 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.39 | |||||
| Operating Margin % | 26.96 | |||||
| Net Margin % | 25.11 | |||||
| FCF Margin % | -4.17 | |||||
| ROE % | 11.6 | |||||
| ROA % | 8.82 | |||||
| ROIC % | 17.07 | |||||
| ROC (Joel Greenblatt) % | 31.28 | |||||
| ROCE % | 11.94 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 74.46 | |||||
| Forward PE Ratio | 38.59 | |||||
| PE Ratio without NRI | 74.46 | |||||
| Shiller PE Ratio | 88.87 | |||||
| Price-to-Owner-Earnings | 125.26 | |||||
| PEG Ratio | 4.33 | |||||
| PS Ratio | 18.93 | |||||
| PB Ratio | 10.13 | |||||
| Price-to-Tangible-Book | 10.8 | |||||
| Price-to-Operating-Cash-Flow | 9266.63 | |||||
| EV-to-EBIT | 62.68 | |||||
| EV-to-EBITDA | 62.68 | |||||
| EV-to-Revenue | 18.67 | |||||
| EV-to-FCF | -426.11 | |||||
| Price-to-Projected-FCF | 10.36 | |||||
| Price-to-Peter-Lynch-Fair-Value | 5.07 | |||||
| Price-to-Graham-Number | 5.98 | |||||
| Price-to-Net-Current-Asset-Value | 86.09 | |||||
| Earnings Yield (Greenblatt) % | 1.6 | |||||
| FCF Yield % | -0.22 | |||||
| Forward Rate of Return (Yacktman) % | 14.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CSPC Innovation Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,043.417 | ||
| EPS (TTM) (Â¥) | 0.37 | ||
| Beta | 1.31 | ||
| Volatility % | 61.91 | ||
| 14-Day RSI | 48.41 | ||
| 14-Day ATR (Â¥) | 1.159381 | ||
| 20-Day SMA (Â¥) | 28.195 | ||
| 12-1 Month Momentum % | -3.19 | ||
| 52-Week Range (Â¥) | 19.691666 - 37.08 | ||
| Shares Outstanding (Mil) | 1,404.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CSPC Innovation Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CSPC Innovation Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
CSPC Innovation Pharmaceutical Co Ltd Frequently Asked Questions
What is CSPC Innovation Pharmaceutical Co Ltd(SZSE:300765)'s stock price today?
The current price of SZSE:300765 is ¥27.55. The 52 week high of SZSE:300765 is ¥37.08 and 52 week low is ¥19.69.
When is next earnings date of CSPC Innovation Pharmaceutical Co Ltd(SZSE:300765)?
The next earnings date of CSPC Innovation Pharmaceutical Co Ltd(SZSE:300765) is .
Does CSPC Innovation Pharmaceutical Co Ltd(SZSE:300765) pay dividends? If so, how much?
The Dividend Yield %  of CSPC Innovation Pharmaceutical Co Ltd(SZSE:300765) is 1.17% (As of Today), Highest Dividend Payout Ratio of CSPC Innovation Pharmaceutical Co Ltd(SZSE:300765) was 0.86. The lowest was 0.11. And the median was 0.13. The  Forward Dividend Yield % of CSPC Innovation Pharmaceutical Co Ltd(SZSE:300765) is 1.17%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers